BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP
Protokinetix, Incorporated PKTX
18 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
EPS · FY24
$0.00
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
-93.6%
Net margin · FY24
—
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
—
Revenue, FY2024 · full 18-year series below
Revenue
Net income
Per share
USD 0.00
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
-93.6%
Return on equity, FY2024
ROE
Operating margin—
Net margin—
Return on assets-76.9%
Each USD of equity lost 94 cents this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.37B
Shares outstanding, FY2024
Change, 5 years+35.0%
Change, 10 years+111.7%
The share count grew 35% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 466,137.00
total assets, end of FY2024
Total assetsUSD 466,137.00
EquityUSD 342,090.00
Equity funds 73% of total assets.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
·
·
·
·
·
·
·
·
·
·
0.0
0.0
0.0
0.0
0.0
·
·
·
Operating income $B
·
·
·
·
·
·
·
·
·
·
·
·
−0.0
−0.0
−0.0
·
·
·
EBITDA $B
·
·
·
·
·
·
·
·
·
·
·
·
−0.0
−0.0
−0.0
·
·
·
Income tax $B
0.0
0.0
·
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
0.00
−0.01
−0.01
0.00
−0.03
−0.02
0.00
−0.01
−0.01
−0.01
0.00
0.00
0.00
−0.01
−0.02
·
·
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−93.6
−96.9
−492.6
−599.4
−1552.8
−1041.2
−392.6
−347.8
−338.4
·
·
·
·
·
·
·
·
·
Shares out B
0.37
0.35
0.32
0.30
0.29
0.28
0.26
0.25
0.24
0.22
0.18
0.14
0.13
0.12
0.08
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
34 of 34
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed